550 related articles for article (PubMed ID: 17326013)
21. Possible involvement of corticotropin-releasing factor receptor signaling on vascular inflammation.
Inada Y; Ikeda K; Tojo K; Sakamoto M; Takada Y; Tajima N
Peptides; 2009 Feb; 30(2):365-72. PubMed ID: 19026699
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of mouse melanoma cell proliferation by corticotropin-releasing hormone and its analogs.
Carlson KW; Nawy SS; Wei ET; Sadée W; Filov VA; Rezsova VV; Slominski A; Quillan JM
Anticancer Res; 2001; 21(2A):1173-9. PubMed ID: 11396159
[TBL] [Abstract][Full Text] [Related]
23. Effects of corticotropin-releasing hormone receptor antagonists on the ethanol-induced increase of dynorphin A1-8 release in the rat central amygdala.
Lam MP; Gianoulakis C
Alcohol; 2011 Nov; 45(7):621-30. PubMed ID: 21840158
[TBL] [Abstract][Full Text] [Related]
24. Neuropeptide urocortin and its receptors are expressed in rat Kupffer cells.
Charalampopoulos I; Androulidaki A; Minas V; Chatzaki E; Tsatsanis C; Notas G; Xidakis C; Kolios G; Kouroumalis E; Margioris AN; Gravanis A
Neuroendocrinology; 2006; 84(1):49-57. PubMed ID: 17090973
[TBL] [Abstract][Full Text] [Related]
25. Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists.
Hoare SR; Sullivan SK; Schwarz DA; Ling N; Vale WW; Crowe PD; Grigoriadis DE
Biochemistry; 2004 Apr; 43(13):3996-4011. PubMed ID: 15049707
[TBL] [Abstract][Full Text] [Related]
26. Expression of CRH, CRH-related peptide and CRH receptor in the ovary and potential CRH signalling pathways.
Wypior G; Jeschke U; Kurpisz M; Szekeres-Bartho J
J Reprod Immunol; 2011 Jun; 90(1):67-73. PubMed ID: 21696829
[TBL] [Abstract][Full Text] [Related]
27. Achieving signalling selectivity of ligands for the corticotropin-releasing factor type 1 receptor by modifying the agonist's signalling domain.
Beyermann M; Heinrich N; Fechner K; Furkert J; Zhang W; Kraetke O; Bienert M; Berger H
Br J Pharmacol; 2007 Jul; 151(6):851-9. PubMed ID: 17533422
[TBL] [Abstract][Full Text] [Related]
28. Corticotropin-releasing factor receptors and urocortins, links between the brain and the heart.
Yang LZ; Tovote P; Rayner M; Kockskämper J; Pieske B; Spiess J
Eur J Pharmacol; 2010 Apr; 632(1-3):1-6. PubMed ID: 20132811
[TBL] [Abstract][Full Text] [Related]
29. Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via R1alpha and R2beta CRH receptor subtypes and stimulation of Gq-proteins.
Grammatopoulos DK; Randeva HS; Levine MA; Katsanou ES; Hillhouse EW
Mol Endocrinol; 2000 Dec; 14(12):2076-91. PubMed ID: 11117536
[TBL] [Abstract][Full Text] [Related]
30. Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor.
Gehlert DR; Shekhar A; Morin SM; Hipskind PA; Zink C; Gackenheimer SL; Shaw J; Fitz SD; Sajdyk TJ
Eur J Pharmacol; 2005 Feb; 509(2-3):145-53. PubMed ID: 15733549
[TBL] [Abstract][Full Text] [Related]
31. In situ expression of corticotropin-releasing hormone (CRH) and proopiomelanocortin (POMC) genes in human skin.
Kono M; Nagata H; Umemura S; Kawana S; Osamura RY
FASEB J; 2001 Oct; 15(12):2297-9. PubMed ID: 11511529
[TBL] [Abstract][Full Text] [Related]
32. Alleviation of the effects of endotoxin exposure on behavior and hippocampal IL-1beta by a selective non-peptide antagonist of corticotropin-releasing factor receptors.
Kohman RA; Tarr AJ; Sparkman NL; Day CE; Paquet A; Akkaraju GR; Boehm GW
Brain Behav Immun; 2007 Aug; 21(6):824-35. PubMed ID: 17339098
[TBL] [Abstract][Full Text] [Related]
33. Neuropeptide urocortin 1 and its receptors are expressed in the human liver.
Simopoulos C; Christodoulou E; Lambropoulou M; Tsaroucha AK; Kakolyris S; Polychronidis A; Karayiannakis AJ; Chatzaki E
Neuroendocrinology; 2009; 89(3):315-26. PubMed ID: 19096201
[TBL] [Abstract][Full Text] [Related]
34. Neuromedin U-induced anorexigenic action is mediated by the corticotropin-releasing hormone receptor-signaling pathway in goldfish.
Maruyama K; Wada K; Ishiguro K; Shimakura S; Wakasugi T; Uchiyama M; Shioda S; Matsuda K
Peptides; 2009 Dec; 30(12):2483-6. PubMed ID: 19699772
[TBL] [Abstract][Full Text] [Related]
35. The role of central corticotropin-releasing hormone in the anorexic and endocrine effects of the bacterial T cell superantigen, Staphylococcal enterotoxin A.
Kaneta T; Kusnecov AW
Brain Behav Immun; 2005 Mar; 19(2):138-46. PubMed ID: 15664786
[TBL] [Abstract][Full Text] [Related]
36. The role of corticotropin-releasing hormone in immune-mediated cutaneous inflammatory disease.
O'Kane M; Murphy EP; Kirby B
Exp Dermatol; 2006 Mar; 15(3):143-53. PubMed ID: 16480421
[TBL] [Abstract][Full Text] [Related]
37. Evolution and physiology of the corticotropin-releasing factor (CRF) family of neuropeptides in vertebrates.
Lovejoy DA; Balment RJ
Gen Comp Endocrinol; 1999 Jul; 115(1):1-22. PubMed ID: 10375459
[TBL] [Abstract][Full Text] [Related]
38. Amygdaloid pERK1/2 in corticotropin-releasing hormone overexpressing mice under basal and acute stress conditions.
Silberstein S; Vogl AM; Refojo D; Senin SA; Wurst W; Holsboer F; Deussing JM; Arzt E
Neuroscience; 2009 Mar; 159(2):610-7. PubMed ID: 19361479
[TBL] [Abstract][Full Text] [Related]
39. Binding differences of human and amphibian corticotropin-releasing factor type 1 (CRF(1)) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonism.
Dautzenberg FM; Wille S
Regul Pept; 2004 May; 118(3):165-73. PubMed ID: 15003833
[TBL] [Abstract][Full Text] [Related]
40. Aging-related changes in cutaneous corticotropin-releasing hormone system reflect a defective neuroendocrine-stress response in aging.
Elewa RM; Abdallah M; Youssef N; Zouboulis CC
Rejuvenation Res; 2012 Aug; 15(4):366-73. PubMed ID: 22533365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
